Boston Scientific
861 hedge funds and large institutions have $51.4B invested in Boston Scientific in 2022 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 331 increasing their positions, 293 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
4% less first-time investments, than exits
New positions opened: 82 | Existing positions closed: 85
8% less call options, than puts
Call options by funds: $232M | Put options by funds: $252M
2% less funds holding
Funds holding: 875 → 861 (-14)
Holders
861
Holding in Top 10
22
Calls
$232M
Puts
$252M
Top Buyers
| 1 | +$909M | |
| 2 | +$207M | |
| 3 | +$203M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$167M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
+$85.5M |
Top Sellers
| 1 | -$585M | |
| 2 | -$116M | |
| 3 | -$79.5M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$70M |
| 5 |
Two Sigma Advisers
New York
|
-$58.9M |